207 related articles for article (PubMed ID: 10864101)
1. Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test.
Lötsch J; Tegeder I; Angst MS; Geisslinger G
Life Sci; 2000 May; 66(24):2393-403. PubMed ID: 10864101
[TBL] [Abstract][Full Text] [Related]
2. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
[TBL] [Abstract][Full Text] [Related]
3. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
Faura CC; Olaso JM; Cabanes CG; Horga JF
Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
[TBL] [Abstract][Full Text] [Related]
4. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
6. Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein.
Lötsch J; Schmidt R; Vetter G; Schmidt H; Niederberger E; Geisslinger G; Tegeder I
J Neurochem; 2002 Oct; 83(2):241-8. PubMed ID: 12423235
[TBL] [Abstract][Full Text] [Related]
7. Morphine antinociception is enhanced in mdr1a gene-deficient mice.
Zong J; Pollack GM
Pharm Res; 2000 Jun; 17(6):749-53. PubMed ID: 10955852
[TBL] [Abstract][Full Text] [Related]
8. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
9. Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice.
Romberg R; Sarton E; Teppema L; Matthes HW; Kieffer BL; Dahan A
Br J Anaesth; 2003 Dec; 91(6):862-70. PubMed ID: 14633759
[TBL] [Abstract][Full Text] [Related]
10. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
Dagenais C; Zong J; Ducharme J; Pollack GM
Pharm Res; 2001 Jul; 18(7):957-63. PubMed ID: 11496955
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
12. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions.
Hassan HE; Mercer SL; Cunningham CW; Coop A; Eddington ND
Int J Pharm; 2009 Jun; 375(1-2):48-54. PubMed ID: 19481690
[TBL] [Abstract][Full Text] [Related]
14. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.
Qian-Ling G; Hedner J; Björkman R; Hedner T
Pain; 1992 Feb; 48(2):249-255. PubMed ID: 1589243
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and chronic administration of L-arginine on the antinociceptive action of morphine-6-beta-D-glucuronide.
Bhargava HN; Bian JT
Pharmacology; 1997 Oct; 55(4):165-72. PubMed ID: 9396075
[TBL] [Abstract][Full Text] [Related]
16. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
[TBL] [Abstract][Full Text] [Related]
17. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
18. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
[TBL] [Abstract][Full Text] [Related]
19. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
20. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats.
South SM; Smith MT
J Pharmacol Exp Ther; 1998 Sep; 286(3):1326-32. PubMed ID: 9732396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]